PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

ABT vs. DHR

Last updated Feb 27, 2024

Compare and contrast key facts about Abbott Laboratories (ABT) and Danaher Corporation (DHR).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or DHR.

Key characteristics


ABTDHR
YTD Return8.35%8.78%
1Y Return20.55%14.51%
3Y Return (Ann)1.46%9.42%
5Y Return (Ann)10.85%18.15%
10Y Return (Ann)13.75%17.93%
Sharpe Ratio0.920.55
Daily Std Dev19.61%23.74%
Max Drawdown-45.62%-60.90%
Current Drawdown-12.56%-13.69%

Fundamentals


ABTDHR
Market Cap$205.95B$187.77B
EPS$3.26$5.66
PE Ratio36.4144.85
PEG Ratio28.673.31
Revenue (TTM)$40.11B$23.89B
Gross Profit (TTM)$24.58B$18.95B
EBITDA (TTM)$10.46B$7.55B

Correlation

0.33
-1.001.00

The correlation between ABT and DHR is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

ABT vs. DHR - Performance Comparison

In the year-to-date period, ABT achieves a 8.35% return, which is significantly lower than DHR's 8.78% return. Over the past 10 years, ABT has underperformed DHR with an annualized return of 13.75%, while DHR has yielded a comparatively higher 17.93% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2024February
16.67%
8.82%
ABT
DHR

Compare stocks, funds, or ETFs


Abbott Laboratories

Danaher Corporation

ABT vs. DHR - Dividend Comparison

ABT's dividend yield for the trailing twelve months is around 1.75%, more than DHR's 0.42% yield.


TTM20232022202120202019201820172016201520142013
ABT
Abbott Laboratories
1.75%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%1.95%1.46%
DHR
Danaher Corporation
0.42%0.45%0.43%0.29%0.37%0.50%0.70%0.68%0.71%0.66%0.47%0.13%

ABT vs. DHR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Danaher Corporation (DHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ABT
Abbott Laboratories
0.92
DHR
Danaher Corporation
0.55

ABT vs. DHR - Sharpe Ratio Comparison

The current ABT Sharpe Ratio is 0.92, which is higher than the DHR Sharpe Ratio of 0.55. The chart below compares the 12-month rolling Sharpe Ratio of ABT and DHR.


Rolling 12-month Sharpe Ratio-0.500.000.501.00SeptemberOctoberNovemberDecember2024February
0.92
0.55
ABT
DHR

ABT vs. DHR - Drawdown Comparison

The maximum ABT drawdown since its inception was -45.62%, smaller than the maximum DHR drawdown of -60.90%. The drawdown chart below compares losses from any high point along the way for ABT and DHR


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%SeptemberOctoberNovemberDecember2024February
-12.56%
-13.69%
ABT
DHR

ABT vs. DHR - Volatility Comparison

The current volatility for Abbott Laboratories (ABT) is 5.01%, while Danaher Corporation (DHR) has a volatility of 7.44%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than DHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2024February
5.01%
7.44%
ABT
DHR